| Heading: |
Sickle Cell Diseases: Research |
| Question ID: |
1789648 |
| UIN: |
42203 |
| House: |
Commons |
| Date tabled: |
2025-03-27 |
| Asking Member ID: |
4124 |
| Asking Member display name: |
Chi Onwurah
|
| Asking Member handle: |
ChiOnwurah
|
| Asking Member Twitter reference: |
@ChiOnwurah
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Science, Innovation and Technology, what assessment his Department has made of the adequacy of levels of research and development funding for sickle cell disorder. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-04 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4822 |
| Answering Member display name: |
Feryal Clark
|
| Answering Member handle: |
FeryalClark
|
| Answering Member Twitter reference: |
@FeryalClark
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
UK Research and Innovation (UKRI) delivers a substantial portfolio of researcher-led projects and strategic investments, including research into sickle cell disease, for which UKRI had expenditure of approximately £0.2 million in 2023-24. UKRI also plays ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
216 |
| Answering body name: |
Department for Science, Innovation and Technology |
| Tweeted: |
true |